S. Egetenmeyer and C. Richert
pylchlorophosphoramidite (140 mL, 0.6 mmol) was added dropwise at
08C, and the solution was stirred under argon. The ice bath was removed
after 10 min and the solution was allowed to warm to room temperature,
followed by stirring for 2.5 h. The mixture was diluted with CH2Cl2
(5 mL), and washed twice with saturated NaHCO3 solution (5 mL) and
brine (5 mL). The organic layer was dried over MgSO4, and CH2Cl2 was
removed in vacuo. The residue was purified by flash chromatography
(silica, pretreated with eluent containing 2% triethylamine, petroleum
ether/ethyl acetate, 2:1, Rf =0.85) to give 23 as a slightly yellow solid
(126 mg, 0.24 mmol, 81%). 31P NMR (121 MHz, CD3CN): d=147.7 ppm;
1H NMR (300 MHz, CD3CN): d=1.15 (dd, J=10.5 Hz, J=15.8 Hz,
12H), 1.85–1.97 (m, 6H), 3.35–3.82 (m, 6H), 4.18–4.48 (m, 2H), 7.29–
7.86 ppm (m, 8H); MS (ESI): m/z calcd for C29H38N3O4P: 546.25
[M+Na]+; found: 546.25.
Experimental Section
General: Extinction coefficients of the modified oligonucleotides were
calculated as the sum of the extinction coefficients of the unmodified
DNA portion and the extinction coefficient of the stacking moieties at
260 nm given in the literature.[40]
UV melting experiments: Melting curve experiments used sodium phos-
phate buffer (10 mm) at pH 7 with NaCl concentrations of 150 mm or 1m
and strand concentrations of 1.0 mm for duplexes of 1 and 2 or 1.5 mm
(each strand) for duplexes of 15–18. For each sample, at least four curves
from 5 to 808C were measured at a heating or cooling rate of 18CminÀ1
.
Melting points were calculated using Templab 2.0, and the values given
are the average of four curves. The hyperchromicity was calculated as the
difference between the absorption at 808C and that at 58C, divided by
the absorption at 58C.
Analytical data for HPLC-purified modified oligonucleotides and the
MALDI-TOF mass spectra of these compounds are given in the Support-
ing Information.
Thermodynamic data: Thermodynamic data was determined by using
Meltwin, version 3.5 through curve fitting, as described in reference [26].
For each duplex, four melting curves of 38 points were run. The values
given are the average of four results Æ1 standard deviation.
DNA synthesis: DNA oligonucleotides were synthesized on a 1 mmol
scale, following a standard protocol of the manufacturer. Caps were in-
troduced following the general protocols given below, after DMT depro-
tection of the DNA strands on controlled pore glass (cpg). General pro-
tocol A was used for the coupling of phosphoramidite-linker building
blocks to the 5’-terminus of the DNA, followed by Fmoc deprotection[21]
with piperidine in DMF (20%) for 20 min, or MMT deprotection[17] with
TCA deblock solution for DNA synthesis, depending on the linker build-
ing block. After deprotection of the terminal amino group of the linker,
general protocol B was used for peptide coupling of Fmoc-protected
amino acids or carboxylic acids. The oligonucleotides were deprotected
and cleaved off the solid support by treatment with aqueous ammonia
(1 mL, 25%) at 558C for 2 h for oligonucleodides with an all-A/T se-
quence, and for 5 h for oligonucleotides with mixed sequences.[21] The
ammonia was removed by blowing a low stream of nitrogen onto the sur-
face of the solution for 1 h, followed by lyophilization.
Acknowledgements
The authors thank Dr. Amritraj Patra and Dr. Michael Printz for sharing
melting curve data used for thermodynamic analyses, Denis Kusevic, Jo-
hanna Spçrl and Ruth Frank for help with the synthesis of the linker
building blocks, Sebastian Spies for providing oligonucleotides 1bCD,
1bFL, 1bCT, 1bIA, 1bPT, 1bPA, 1bAT, 1bNP, 1bPY, and 1bPQ, Dr.
Eric Kervio for suggesting the use of 2’-fluoro-2’-deoxyuridine, and
Helmut Griesser, Andreas Kaiser, Cora Prestinari, and Heike Vogel for a
review of the manuscript. This work was supported by DFG (grant No.
RI 1063/9–1) and the MINT program of the Ministry for Science Re-
search and the Arts Baden-Wꢂrttemberg (MWK) and febit holding
GmbH (Heidelberg, Germany).
[1] M. Egli, W. Saenger, Principles of Nucleic Acid Structure, Springer,
New York, 1984.
Coupling of linker phosphoramidites to DNA (general protocol A): This
protocol is similar to that reported earlier for manual chain extension of
DNA.[17,23] Linker phosphoramidites (5a–e, 8–14, 23, and 28–30, ca. 1 mg,
2 mmol, 60 equiv) were dried together with the DNA-bearing cpg (5 mg,
ca. 0.16 mmol loading) for 2–20 h at 0.1 mbar. After addition of activator
solution (0.25m 4,5-dicyanoimidazol in CH3CN, 40 mL) under argon, the
mixture was agitated at 240 rpm on a vortexer for 2 h. Oxidizer solution
for DNA synthesis (0.02m I2 in pyridine, THF, and water, 100 mL) was
then added, and the mixture was again shaken for 15 min. The superna-
tant was removed, and the cpg was washed five times with acetonitrile
(0.5 mL). Analytical samples were deprotected and cleaved from the cpg
and evaluated by MALDI-TOF MS.
Micura, Angew. Chem. 2004, 116, 4797–4799; Angew. Chem. Int.
Ed. 2004, 43, 4692–4694; d) R. T. Batey, S. D. Gilbert, R. K. Mon-
[3] a) S. M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber,
Seto, J. Kim, S. Kuramochi-Miyagawa, T. Nakano, D. P. Bartel, R. E.
[5] V. Ambros, B. Bartel, D. P. Bartel, C. B. Burge, J. C. Carrington, X.
Chen, G. Dreyfuss, S. R. Eddy, S. Griffiths-Jones, M. Marshall, M.
Peptide coupling on cpg (general protocol B): This procedure is similar
to earlier protocols.[19d] The DNA-bearing cpg with strands with a termi-
nal free amino group (6a–f, 6t, 7b–d, 24–27; 5–7 mg, ca. 0.16 mmol DNA)
were dried in a reaction vessel. The carboxylic acid (10 mmol) and HBTU
(3 mg, 8 mmol) in DMF (100 mL) were treated with DIEA (4 mL,
31 mmol). After 5–20 min, the mixture was transferred to the cpg, fol-
lowed by shaking for 15 min. In cases of low solubility of the carboxylic
acid, the mixture was heated to 558C during the activation until a clear
solution formed. After 20 min, the supernatant was removed and the cpg
was washed twice with DMF (0.5 mL) and acetonitrile (0.5 mL).
[6] S. Ambs, R. L. Prueitt, M. Yi, R. S. Hudson, T. M. Howe, F. Petroc-
ca, T. A. Wallace, C. G. Liu, S. Volinia, G. A. Calin, H. G. Yfantis,
[7] For recent reviews, see: a) A. W. Wark, H. J. Lee, R. M. Corn,
644–652; b) B. Zhang, X. Pan, G. P. Cobb, T. A. Anderson, Dev.
[10] P. E. Nielsen, Curr. Pharm. Des. 2010, 16, 3118–3123.
[12] a) S. Schmidt, A. Niemann, N. F. Krynetskaya, T. S. Oretskaya, V. G.
Metelev, V. V. Sukhomlinov, Z. A. Shabarova, D. Cech, Biochim.
HPLC purification: Modified oligonucleotides were purified by HPLC
on a 250 mmꢅ4.6 mm 120–5 Nucleosil C4 or C18 column (Macherey–
Nagel, Dꢂren, Germany) with a gradient of CH3CN in triethylammonium
acetate buffer (TEAA; 0.1m, pH 7). Yields are based on the amount of
isolated pure product, compared to the loading of the cpg. Pure fractions
were lyophilized, taken up in water, and lyophilized again.
O-2-Cyanoethyl-O-[N-fluorenylmethylcarboxyl)-(S)-pyrrolidin-3-meth-
ACHTUNGTRENNUNG
ACHTUNGTRENNUNG
11826
ꢄ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2011, 17, 11813 – 11827